#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type I Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Small cell lung cancer recurrent Congenital pseudarthrosis Leukodystrophy Fms-like tyrosine kinase 3 positive Philadelphia positive acute lymphocytic leukaemia Epileptic encephalopathy Primary immunodeficiency syndrome Cutaneous T-cell lymphoma recurrent Muscular dystrophy Liver transplant rejection General anaesthesia Heart disease congenital Mantle cell lymphoma recurrent More trials…

    Learn about Rare Diseases

    Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Life with Disease Osteosarcoma – Diagnostics Atypical teratoid/rhabdoid tumour of CNS Acquired haemophilia – Treatment Primary biliary cholangitis – Trials in Disease Familial haemophagocytic lymphohistiocytosis – Treatment Epidermolysis bullosa – Life with Disease Chordoma – Treatment Ornithine transcarbamoylase deficiency Malignant fibrous histiocytoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Star-0215 Amniotic Membrane, Human Efinopegdutide VINBLASTINE Naproxen Tenecteplase Rosuvastatin Vorinostat Rifapentine Nitrogen Micronised Spironolactone Casimersen Bupivacaine Hydrochloride Follitropin Beta Hhalpc Aciclovir Mavacamten Folinic Acid Arginine Hydrochloride Anhydrous Cholestyramine More therapies…

    Learn about Your Condition

    Leiomyosarcoma metastatic Pancreatitis acute Lung disorder Blood disorder Spinal pain Hand fracture Mumps Kidney transplant rejection Triple negative breast cancer Acquired haemophilia Intermittent claudication Mast cell activation syndrome Normal pressure hydrocephalus IgA nephropathy Vestibular disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study to compare how the body absorbs empagliflozin tablets in healthy individuals.

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Empagliflozin
    Portugal

  • Evaluation of Retinol Palmitate Administration and Serum Levels in Preterm Infants with Bronchopulmonary Dysplasia: A Phase 2a Open-Label Study

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Retinol Palmitate
    Germany Poland

  • Evaluation of Pembrolizumab, Patritumab Deruxtecan, and Drug Combinations in Stage IV Non-Small Cell Lung Cancer: A Phase 2 Umbrella Study

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    Investigated Drugs:
    • Patritumab Deruxtecan
    • Pemetrexed Disodium
    • Carboplatin
    Greece Hungary Italy Poland Spain

  • Efficacy and Safety Evaluation of Belantamab Mafodotin Versus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Belantamab Mafodotin
    • Dexamethasone
    • Dexamethasone Ph. Eur.
    Belgium Bulgaria France Germany Greece Hungary +4

  • Phase 1 Study of REN001 Single‑Dose Pharmacokinetics in Adults with Normal, Mild, Moderate, or Severe Liver Impairment

    Not recruiting

    1 1 1
    Hungary

  • Comparison of montelukast 10 mg capsules and montelukast 10 mg film-coated tablets in healthy volunteers to evaluate how the medicine is absorbed.

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Montelukast
    Spain
Previous Page
1 … 924 925 926 927 928 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!